Topotecan-induced celluitis-like fixed drug eruption

J Eur Acad Dermatol Venereol. 2002 Jul;16(4):414-6. doi: 10.1046/j.1468-3083.2002.00570_3.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Biopsy, Needle
  • Cellulitis / chemically induced*
  • Cellulitis / pathology
  • Chemotherapy, Adjuvant / adverse effects
  • Cystadenocarcinoma, Serous / drug therapy*
  • Cystadenocarcinoma, Serous / pathology
  • Cystadenocarcinoma, Serous / surgery
  • Dose-Response Relationship, Drug
  • Drug Eruptions / diagnosis*
  • Drug Eruptions / pathology
  • Fatal Outcome
  • Female
  • Humans
  • Hysterectomy / methods
  • Infusions, Intravenous
  • Leg Dermatoses / diagnosis
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery
  • Ovariectomy / methods
  • Risk Assessment
  • Topotecan / administration & dosage
  • Topotecan / adverse effects*

Substances

  • Topotecan